@ Southeast BIO

"Southeast BIO (SEBIO)'s mission is to foster the growth of the life sciences industry in the Southeastern United States by promoting entrepreneurship and bringing together the key stakeholders active in the development of the industry."

G1 Therapeutics files for $115M IPO

G1 Therapeutics Inc., a clinical-stage biopharmaceutical company based in the Research Triangle Park, filed Thursday for an initial public offering of $115 million.

read more

2017 Investor Forum – back in Pinehurst, N.C.!

Come join us at the Pinehurst Resort, November 14-16, 2017!  More information to come soon!

read more

David Day named as Executive Director of Southeast BIO

The Board of Directors for Southeast BIO (SEBIO) is pleased to announce the appointment of David L. Day as Executive Director, effective immediately.

read more